MD Class of 2026
Co-founder of nCase Technologies
Making life-saving medication accessible when it counts
While earning her medical degree, Dani Wilder, MD ‘26, co-founded nCase Technologies, a St. Louis-based startup that creates cases that securely and discreetly hold naloxone nasal spray, the life-saving drug that can reverse the effects of an opioid overdose. The idea arose from the sobering realization that even among those who already know the importance of naloxone, most frequently sold as Narcan, the vast majority don’t carry it regularly.
Wilder sees this pattern regularly in her work in emergency medicine. Tragically, as a teenager it affected her innermost circle.
“Back in 2018, I lost a close friend to an opioid overdose,” said Wilder, who matched into emergency medicine at the Hospital of the University of Pennsylvania in Philadelphia. “He owned Narcan, and those he was with also owned Narcan, but none of them had it on them when his life depended on it.
And fast forward, when I got training in medical school, people received Narcan and then didn’t have it when they needed it most. That’s when we started realizing there was a problem. I wondered, ‘how do I get myself to carry Narcan? How do I get people to build it into their everyday lives?’”
Through research, Wilder and her now husband, Matt Bitner-Glindzicz, a WashU McKelvey Engineering graduate, discovered a set of simple but persistent barriers to carrying naloxone: bulkiness, inconvenience, stigma.
The solution? An unassuming, keychain-sized NALOX-1 case that is waterproof, UV- and temperature-resistant, comfortable to hold and durable. Appearance-wise, it intentionally looks more like “a cute accessory” than a medical device.
As of June 2026, the technology has saved a total of 40 lives. Since so many overdose incidents go unreported, Wilder and Bitner-Glindzicz suspect that number is even higher. And they’re determined to save even more.